← FDA DRUG APPROVALS

FDA NDA · NDA019421

EXIDINE

Sponsor: XTTRIUM

APPLICATION
NDA019421
TYPE
NDA
ORIGINAL APPROVAL
1985-12-17
LATEST ACTION
1988-05-10
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

EXIDINEDiscontinued
CHLORHEXIDINE GLUCONATE 2.5% · SOLUTION · TOPICAL

Approval history

1988-05-10Manufacturing (CMC) · Supplement 2 · standardAP
1985-12-17Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →